Provider review
Omzo review
Daily oral GLP-1 kits whose starting prices are only the first month.
Reviewed by Lena OrtizMetabolic Health Editor
Price updated October 2026
We may earn a commission at no extra cost to you. Affiliate partners are listed first on our rankings. How we’re funded.
Oral kits from $179 sema, $279 tirz; terms list $299 and $399 follow-ups
Visit OmzoIts terms list follow-up packages well above the advertised starting figures.
Price as published
Omzo
Oral kits from $179 sema, $279 tirz; terms list $299 and $399 follow-ups
- Vs median
- Not comparable — no per-month rate is published — the verified string carries no monthly figure
- Market
- $59–$1,300/mo across 299 of 548
- Structure
- Standard plan, self-directed low dose
- Dispensed
- Pharmacy not publicly identified
Advertising disclosure · we may earn a commission if you start care through some of these links, at no extra cost to you.
In one paragraph
The verdict
Omzo's main product is a custom daily oral kit of compounded semaglutide or tirzepatide, prescribed by a third-party clinician network, which suits anyone who would rather not inject. The advertised prices need reading against its terms. The homepage shows a starting figure for each drug, and the terms show what those figures are: initial consultation packages, followed by follow-up packages that cost noticeably more. The terms even give a different starting figure for tirzepatide than the homepage does. So budget on the follow-up price, not the starting one. Branded drugs can be prescribed, and Omzo fulfills them only in limited cases. The refund policy is tight: once you submit the medical intake, the order is non-refundable unless a provider finds you ineligible, and requests after 28 days are refused. The pharmacy is not named, no dose is published, and there is no low-dose product.
Microdosing is off-label and unproven — decide with a clinician. Prices are as published by the provider when we last checked; confirm current terms before you buy.
Who it suits, and who it does not
A good fit if
- You want a needle-free daily oral option for either molecule
- You are comfortable budgeting on the follow-up price
- You want branded drugs available as a fallback
Look elsewhere if
- You want the advertised price to be what you pay every month
- You want a refund window after your intake
- You want a low-dose product
What it actually costs
Price as published
Oral kits from $179 sema, $279 tirz; terms list $299 and $399 follow-ups
- Vs median
- Not comparable — no per-month rate is published — the verified string carries no monthly figure
- Market
- $59–$1,300/mo is the full published spread on this site
- Structure
- Standard plan, self-directed low dose
No low-dose product of its own. Starting low means asking for a smaller amount inside a standard plan, at the standard plan's price.
235 of the 548 programs here price a small dose this way. Both molecules come as daily oral kits, but the homepage starting figures match only the first package in its terms, which prices follow-ups higher, so no figure holds as the standing rate. No low-dose product exists.
Microdosing is off-label and unproven — decide with a clinician. Prices are as published by the provider when we last checked; confirm current terms before you buy.
What is included
- Consult
- Included in the price
- Dietitian
- Not confirmed
- Labs
- Not required
- Pricing
- Check plan terms
What it does well
- A needle-free route: both molecules come as daily oral kits
- Starting prices are shown before intake
- A full refund is promised if a provider finds you medically ineligible at the first consultation
- Branded drugs can be prescribed when they fit
Pharmacy, labs and oversight
Omzo does not publicly identify the pharmacy that fills its prescriptions. No bloodwork is required before you start. A clinician review is included in the price.
Transparency check
1 of 4 published openly
What Omzo publishes about itself, read from its own pages when we verified them — not estimated, and not a score.
- Pharmacy named and regulatedNo pharmacy is identified anywhere on its own pages.
- Not published
- A price you can read before intakeThe figure appears only after an intake quiz, so it cannot be compared before signing up.
- Not published
- What a higher dose costsPriced by dose, plan or tier, and the higher rungs are not published — the advertised figure does not tell you what a larger dose costs.
- Not published
- No FDA warning letter on fileChecked against the FDA's own warning-letter database; nothing on file for this company.
- None on file
How the program works
Omzo is a telehealth platform whose main product is a custom daily oral kit of compounded semaglutide or tirzepatide, prescribed by a third-party network of U.S.-licensed clinicians and dispensed by an independent compounding pharmacy that is not named. It says branded drugs such as Ozempic and Zepbound are available by prescription only, and fulfilled by Omzo only in limited cases. The homepage advertises starting prices, while its terms describe an initial consultation package and higher follow-up packages. Its terms say it serves the 50 states.
The honest cons
The homepage starting prices match only the first package; its terms list follow-ups at $299 and $399
- The terms price the tirzepatide starter at $259 while the homepage says $279
- Once the intake is submitted, the order is non-refundable, and refund requests after 28 days are refused
- The pharmacy is not named, and no dose is published
- No low-dose product exists
- Compounded GLP-1s are not FDA-approved, and intentional microdosing is off-label and unproven
Microdosing is off-label and unproven — decide with a clinician. Prices are as published by the provider when we last checked; confirm current terms before you buy.
How it compares
Omzo is one of 548 low-dose GLP-1 programs compared on this site, and 299 of them publish a monthly rate you can read before signing up. The full list puts every published price in one place, with the companies that pay us listed first — something we state there, on the page it applies to.
Also consider
Two more programs that price a small dose the way Omzo does. Both are partners: we may earn a commission if you start care through these links.
Partner
Sesame Care
Wegovy pill from $149/mo + sub
Standard plan, self-directed low dose
Partner
RxSpan MD
$249/mo month to month ($199 on 6-mo)
Standard plan, self-directed low dose
Where this sits
#482 of 548
Ordered with the companies that pay us first, and Omzo is not one of them. A disclosed partition, not a score.
Compare all 548 providers →Read this before you buy
Intentional GLP-1 microdosing is off-label and unproven — no randomized trial has established that a sub-label dose does anything, and any dose belongs with a clinician who knows your history. If you are going to have that conversation, have it with real numbers.
- Sublingual troches and drops
- Oral semaglutide (Rybelsus)
- Is compounded GLP-1 safe?
- The true annual cost of a plan
- Microdose & reconstitution calculator
Microdosing is off-label and unproven — decide with a clinician. Prices are as published by the provider when we last checked; confirm current terms before you buy.
The closest alternative
HealthRX
$190/mo sema · $239/mo tirz (monthly plan)
- Vs median
- $15/mo above the $175 median
- Market
- $59–$1,300/mo across 299 of 548
- Structure
- Standard plan, self-directed low dose
- Dispensed
- Pharmacy not publicly identified
Advertising disclosure · we may earn a commission if you start care through some of these links, at no extra cost to you.
Read the HealthRX review →Microdosing is off-label and unproven — decide with a clinician. Prices are as published by the provider when we last checked; confirm current terms before you buy.